[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 92
Citations 0
In This Issue of JAMA Otolaryngology
December 2014

Highlights

JAMA Otolaryngol Head Neck Surg. 2014;140(12):1095. doi:10.1001/jamaoto.2013.4325

As the Conley Lecturer for the combined International Federation of Head and Neck Oncologic Societies and the Annual Meeting of the American Head & Neck Society in July, Fojo made a cogent presentation on how the cost of cancer therapy is rapidly increasing, as is the incidence of cancer, and that this cost is being driven by the use of expensive drug therapies with marginal benefits. He argues that the use of these expensive therapies is cannibalizing time, money, and resources for marginal indications and less than impressive results and that this continued practice is reducing innovation and creativity.

First Page Preview View Large
First page PDF preview
First page PDF preview
×